Eur. Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln,2016, 01, 37-43, Walpurgis K, Thomas A, Vogel M, Reichel C, Geyer H, Schänzer W, Thevis M. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. Lawley JS, Gatterer H, Dias KA, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Hendrix M, Piper T, Thevis M, Levine BD. Clinical Chemistry, 42 (1996) 1001-1020 Seinsch, I., Sigmund, G., Horning, S., Donike, M.: Detection of salbutamol in horse urine. Analytical and Bioanalytical Chemistry (2019) 411:7563–7571. Rapid Commun Mass Spectrom. Recent advances in doping analysis (19). Recent advances in doping analysis (13). Wiley-Blackwell, 2009, 285-303 Thomas A, Kohler M, Walpurgis K, Schänzer W, Thevis M: Proteolysis and autolysis of proteases and the detection of degradation products in doping control. Available online 24 August 2017, doi.org/10.1016/bs.mie.2017.07.013. Sport und Buch Strauß, Köln (1999) 243 256 Flenker, U., Nolteernsting, E., Geyer, H., Schänzer, W.: A Screening method for synthetic testosterone and ist precursors based on GC/C/IRMS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Anal Bioanal Chem. Book of Abstracts des "Joint Meeting of the Austrian and German Pharmaceutical Societies: Shaping the future – Trends and perspectives in pharmaceutical sciences", 20.–23.09.2011, Innsbruck, Austria. Mol Cell Endocrinol. In Spitzer G und Franke E (Hrsg.) Doping im Sport-Zwischen biochemischer Analytik und sozialem Kontext-. 2011 Apr 1. Recent dvances in doping analysis (26). Cardiorespiratory Fitness (VO2max) on elderly subject with Fitmate MED as shown on Dutch television . Eur J Mass Spectrom. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) 91 (2002) 357 362 download als PDF-file Wingender, A., Sigmund, G., Schänzer, W.: Local Anaesthetics in Sport. Drug Test. Fußhöller G, Guddat S, Schänzer W, Geyer H, Thevis M: Testolactone – Derivatisation Artifact due to the Incorporation of an Ethylmercapto Group. Effects of insulin and analogues on carcinogen-induced mammary tumours in high fat-fed rats. Der Basis-Fitness-Test (BFT) ist in der Bundeswehr ein evaluiertes leistungsdiagnostisches Testverfahren, mit dem unter standardisierten Bedingungen die individuelle Leistungsfähigkeit erfasst wird und über ein Punktesystem eine alters-, geschlechts- und statusunabhängige Leistungsbewertung möglich ist.. Diese Seite wurde zuletzt am 27. Sportverlag Strauß, Köln (2014) 196 198 Ojanperä I, Sajantila A, Vinogradova L, Thomas A, Schänzer W, Thevis M Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. Eur.J.Mass Spectrom. Oslo, Norway (2009) 259 Koehler K, Huelsemann F, deMarees M, Braun H, Mester J, Schaenzer W. Nutrition strategies for a 3-week solo dessert crossing: a case study. 2016 May 10;123:132-40 Vogel M, Dib J, Tretzel L, Piper T, Thomas A, Schänzer W, Thevis M. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry. J Mass Spectrom, 43 (2008) 639 50 Thevis M, Schänzer W: Mass spectrometry of selective androgen receptor modulators. Breidbach, A., Platen, P., Schänzer, W.: Erythropoietine-Influence of physical strain and application on blood and urine. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Thevis M, Volmer D. Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation. Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M. Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS. Sport und Buch Strauß, Köln (2001) 35 42 Thevis, M., Opfermann, G., Schänzer, W.: Synthesis and GC/MS-characterisation of glucuronide conjugates of anabolic steroids. Biomed Chromatogr, 21 (2007) 164 168 Parr MK, Orlovius A, Guddat S, Gütschow M, Thevis M, Schänzer W: Sulfoconjugates of heavy volatile nitrogen containing doping substances utilizing LC-MS/MS. Epub 2019 Sep 11. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Anal. 2018; 410: 2275-81 Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing. Sport und Buch Strauß, Köln (1995) 269-274. Philippka-Sportverlag, Münster 2010, 58-61 Green RP, Hollander AS, Thevis M, Thomas A, Dietzen DJ: Detection of surrepititious administration of analog insulin to an 8-week-old infant. In: Houghton E, Ipek Keskin F, Wade JF, Yazicioglu N (eds.) Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln,2016, 01, 37-43 Walpurgis K, Thomas A, Vogel M, Reichel C, Geyer H, Schänzer W, Thevis M. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum … In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Z. Sportmed. 16th annual congress of the European College of Sport Sciences, Book of abstracts. Recent advances in doping analysis (16). 2011 Feb;46(2):112-30 Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Sport und Buch Strauß, Köln (2006) 403 406 Kohler M, Parr MK, Opfermann G, Schaenzer W:Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone. Bruges, Belgium (2012), 590 Kohler, M.; Sandberg, A.; Kjellqvist, S.; Thomas, A.; Karimi, R.; Nyren, S.; Eklund, A.; Thevis, M.; Skold, C. M.; Wheelock, A. M., Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. Lebensmittelchemie, 62 (2008) 76 Parr MK, Koehler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. Sportverlag Strauß, Köln (2007) 393 396 Geyer H, Köhler K, Mareck U, Parr MK, Schänzer W, Thevis M: Nutritional supplements cross-contaminated and faked with prohormones, "classic" anabolic steroids and "designer steroids". Recent advances in doping analysis (15). Sport und Buch Strauß, Köln, (1999) 31 40 Breidbach, A., Schänzer, W.: Erythropoietin with Nichols Institute Diagnostics Chemiluminescence Immunoassay for Erythropoietin after Gelfiltration. Book of Abstracts (2007) Flenker U, Güntner U, Schänzer W: Delta13C-Values of endogenous urinary steroids, Steroids, 73(4) (2008) 408 16. Drug Test Anal . Rapid Commun Mass Spectrom. Drug Test Anal. Rapid Commun. Mareck-Engelke U., Geyer H. and Donike M.: Stability of steroid profiles (2): Excretion rates from morning urines. Recent advances in doping analysis (14). Growth Horm IGF Res. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) 5 (2004) 440 443 Schrader, Y., Schänzer, W.: Plasma levels of 19-norsteroids after administration of oral and sublingual norandrostendione. Biomed. Epub 2015 Jul 24 Semenistaya E, Zvereva I, Thomas A, Thevis M, Krotov G, Rodchenkov G. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Lahmheit und Leistung. 663 (2008) 37 Schänzer W, Thevis M, Geyer H: Dopingkontrollen, Dopingfallen und neue Dopingsubstanzen. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Journal of Steroid Biochemistry & Molecular Biology 121 (2010) 528–537. 21 (2004) 632-640. 2020 Oct 23:bjsports-2019-101961. 2010 Nov;2(11-12):637-642 Maxie Kohler, Katja Walpurgis, Andreas Thomas, Markus de Maree, Joachim Mester, Wilhelm Schänzer and Mario Thevis: Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MS. Proteomics Clin Appl, 4 (2010) 568–576. Juni 2020 um 21:53 Uhr bearbeitet. Toxicol. de Oliveira FA, Casilli A, Piper T, da Silva TR, da Silva CA, da Silva RVS, Dal Sasso MA, Salgueiro GRDSG, Padilha MC, Pereira HMG, Thevis M, Aquino Neto FR. Analysis 2009, 1, 554-567 Schenk I, Machnik M, Guddat S, Schubert D, Schänzer W: Stability of a representative selection of drugs in horse blood. September 2001, Universität Würzburg, Kurzreferate Sammelband (2001) 27 Machnik, M, Schrader, Y., Schänzer, W.: Plasma levels of 19-norsteroids after oral and buccal administration of norandrostendione. Sportverlag Strauß, Köln (2009) 81 90 2008 Bredehöft M, Schänzer W, Thevis M: Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Kurzbeiträge. Sport und Buch Strauß, Köln (2002) 191 204 PDF-file Vogt, A.M., Geyer, H., Jahn, L., Schänzer, W., Kübler, W.: Kardiomyopathie assoziiert mit unkontrollierter Selbstmedikation anaboler Steroide. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 201-207 Thevis M, Schänzer W: Synthetic anabolic agents: Steroids and nonsteroidal selective androgen receptor modulators. Sport und Buch Strauß, Köln , (1997) 319 321 Flenker, U., Nolteernsting, E., Schänzer, W., Donike, M.: Detection and classification of different male steroid profiles by means of multivariate statistics. Sport und Buch Strauß, Köln (2003) 169 178 Kuuranne, T., Kurkela, M., Thevis, M., Schänzer, W.; Finel, M., Kostiainen, R.: Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. 38 (2003) 1197 1206. download als PDF-file Thevis, M,. 25 Jahre Trainerausbildung. in: M. Donike, H. Geyer, A. Gotzmann, U.Mareck-Engelke, S.Rauth (Eds.) Recent advances in doping analysis (19). Recent advances in doping analysis (15). Meyer & Meyer, Aachen (2009) 93–96 Köhler K, de Marees M, Braun H, Schaenzer W. Comparison of two portable devices for assessing energy expenditure during high-intensity running. Proceedings of the 16th international conference of racing analysts and veterinarians. Walpurgis K, Rubio A, Wagener F, Krug O, Knoop A, Görgens C, Guddat S, Thevis M. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. Spectroscopy Europe, 2010, 22, 6-11 Thevis M: Mass spectrometry in sports drug testing: characerization of prohibited substances and doping control analytical assays. 2016. Schenk I, Broussou D, Düe M, Guddat S, Machnik M, Röttgen H, Schänzer W, Toutain PL. Adv Clin Chem. Schänzer W.: Detection of Exogenous Anabolic Androgenic Steroids. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) BMC Vet Res. Sportverlag Strauß, Köln (2014) 102 109 Zhang L, Thevis M, Piper T, Jochmann MA, Wolbert JB, Kujawinski DM, Wiese S, Teutenberg T, Schmidt TC Carbon Isotope Ratio Analysis of Steroids by High-Temperature Liquid Chromatography-Isotope Ratio Mass Spectrometry. Recent advances in doping analysis (5). Leistungssport 1 (1992) 5-8. 15,(1994) 366 Donike, M., Geyer, H., Rauth, S.: Entwicklung der Steroidprofile und der Wettkampfleistungen im Gewichtheben 1989 und 1990 nach Einführung von strikten Dopingkontrollen, Steroidprofile im Sport - 3. Czimek, J. Sportverlag Strauß, Köln (2007) 283 292 Parr MK, Zapp J, Becker M, Opfermann G, Bartz U, Schänzer W: Steroidal isomers with uniform mass spectra of their per-TMS derivatives: Synthesis of hydroxyandrostan-3-ones, androst-1-, and -4-ene-3,17-diols. Endocrinol. In: Castell LM, Stear SJ, Burke LM (eds.). 2014, 28, 1501–1506 Mario Thevis, Andreas Thomas,Thomas Piper,Oliver Krug, Philippe Delahaut and Wilhelm Schänzer. Sport und Buch Strauß, Köln (1995) 51 58. Drug Test Analysis 2018; 10 (6): 938-946. Eur.J.Mass.Spectrom., 13 (2007) 213 221 Thevis M, Schänzer W: Doping mit neuen Medikamenten. 14th annual congress of the European College of Sport Sciences, Book of abstracts. 2015 Jul;407(18):5365-79 Christian Görgens, Sven Guddat, Josef Dib, Hans Geyer, Wilhelm Schänzer and Mario Thevis: Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry. Sportverlag Strauß, Köln (2018) 118–121. Sport und Buch Strauß, Köln (2006) 299 306 Friedel, A., Geyer, H., Kamber, M., Laudenbach-Leschowsky, U., Schänzer. 934-941 Friedmann T, Flenker U, Georgakopoulos C, Alsyrafi M, Williams SA, Gill RD. Mohr Siebeck, Tübingen, 2010, 13-21 Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W: Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) So seien einige Übungen in dem Test unnötig. Biochemistry, 46 (2007) 225 233 Binczek E, Jenke B, Holz B, Günter RH, Thevis M, Stoffel W: Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. Recent advances in doping analysis (14). Sportverlag Strauß, Köln (2019) 98 102. Sport und Buch Strauß, Köln (2002) 205 210 PDF-file Kuk, von C., Schänzer, W.:Estrogens as Additional Parameters of Steroidprofile in Doping Analysis. Doch auch die Tests an anderen Universitäten die ein Sportstudium anbieten, sind ohne Training nur schwer zu bestehen und … Juli nach Köln zu entführen. J. Chrommatogr. 2010 Nov;2(11-12):620-9 Piper T, Opfermann G, Thevis M, Schänzer W. Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates. Machnik M, Wagner S, Schenk I, Broussou D, Toutain PL, Düe Kietzmann M. Schänzer W. Treatment of Competition Horses with Corticosteroids: Elimination and Detection Times of Flumethason in the Horse after I.V. Forensic Sci Int. 2014, 28, 1194 202. doi: 10.1002/rcm.6891. 2014 Dec 16;86 (24):12014-21. Anal. Drug Test Anal. [Epub ahead of print] Hoerner NR, Braun H, Schänzer W, Köhler K. The effect of energy restriction on exercise-induced release of hormone and metabolites. Recent advances in doping analysis (17). Hanisch, F.-G., Witter, B., Crombach, G. A., Schänzer, W., Uhlenbruck,G. Widder, R.A., Bartz-Schmidt, K.U., Geyer, H., Brunner, R., Kirchoff, B., Donike, M., Heinmann, K.: Candida albicans endophthalmitis after anabolic steroid abuse. Sport und Buch Strauß, Köln (1994) 33 40. Conf. 2013, 5, 896-899 Karsten Koehler, Silvia Achtzehn, Hans Braun, Joachim Mester, and Wilhelm Schänzer: Comparison of self-reported energy availability and metabolic hormones to assess adequacy of dietary energy intake in young elite athletes. Recent advances in doping analysis (12). Recent advances in doping analysis (27). Pütz M, Piper T, Schänzer W, Thevis M: In vitro metabolism studies of SARM YK-11. Thomas A, Thevis M. Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy. Drug Test Anal. Mass Spectrom. 2013, 27, 1173–1182. Sport und Buch Strauß, Köln (2002) 35 50 PDF-file Parr, M.K., Geyer, H., Reinhart, U., Schänzer, W.:Approaches towards an Improved Analysis of Nutritional Supplements for Anabolic Androgenic Steroids. Epub 2012 Jul 31. M, Ambroži? Sport und Buch Strauß, Köln (2003) 91 100 Mareck, U., Kress, A., Schwarz, U.W., Geyer, H., Schänzer, W.: Feasibility Study on Commercially Available THC Drug Screen Test Devices. USADA 2009, 204-239 Thevis M, Schänzer W: Performance-enhancing drugs. 03.04.2018 11:16 Physical activity and fitness – an effective approach against dementia? Sports Med. F.I.T., Wissenschaftsmagazin der Deutschen Sporthochschule Köln, Oktober (2000) 14 17. Pharmakokinetische Überlegungen. Drug Test Anal. The aim of this study was to compare the effects of short-term strength training with and without superimposed whole-body electromyostimulation (WB-EMS) on straight sprinting speed (SSS), change of direction speed (CODS), vertical and horizontal jumping, as well as on strength and power in physically active females. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) 43 (2008) 865 876 Thevis M, Geyer H, Schänzer W: Dopingkontrollaktivitäten in Deutschland 1989 2006. Sportverlag Strauß, Köln (2010) 109 117 Thomas A, Beuck S, Eickhoff JC, Guddat S, Krug O, Kamber M, Schänzer W, Thevis M: Quantification of urinary AICAR concentrations as a matter of doping controls. Recent advances in doping analysis (17). Piper T, Schänzer W, Thevis M. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability. [Epub ahead of print] Garg N, Hansson A, Knych HK, Stanley SD, Thevis M, Bondesson U, Hedeland M, Globisch D. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control. Doping-Forum - Aktuelle rechtliche und medizinische Aspekte-Boorberg-Verlag, Suttgart, München, Hannover, Berlin, (2000) 17 26 Schänzer, W.: Dopingkontrollen und aktueller Stand der Nachweismethoden. 14th annual congress of the European College of Sport Sciences, Book of abstracts. Mareck-Engelke, U., Geyer, H., Donike, M: Stability of steroidprofiles (3): Ratios and excretion rates of endogenous steroids in male urines collected over 24 hours. Arzneiverordnung in der Praxis, 33 (2006) 4-6 Schänzer W, Geyer H, Fußhöller H, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M: Mass spectrometric identification and characterization of a new long-term metabolite of Metandienone. 46 (Sonderheft) (1995) 458-463. Die Trainerakademie Köln. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo (1990), 107-116. of the 20th Int. Thevis M, Piper T, Geyer H, Schaefer MS, Schneemann J, Kienbaum P, Schänzer W. Urine analysis concerning xenon for doping control purposes. Recent advances in doping analysis (25). Sportverlag Strauß, Köln (2008) 285 288 Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M: Nutritional supplements cross-contaminated and faked with doping substances. Mareck U, Gougoulidis V Flenker U, Schänzer W (Cologne): Case study: GC/C/IRMS data of an unsusual urine sample. Sport und Buch Strauß, Köln, (1999) 301 310 Breidbach, A., Schänzer, W.: Individual Reference Ranges for serum Erythropoietin (sEPO) - A Possible Approach to Detect Misuse. J Sports Sci. Sport und Buch Strauß, Köln (1996) 201-213. ]Drug Test Anal. Krug O, Thomas A, Geyer H, Thevis M: Testing doping agents from exhaled breath – Pilot study data. 2012 May 7. doi: 10.1002/dta.1361. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Dtsch Z Sportmed. Anal Bioanal Chem. Mass Spectrom Rev. Analytica Chimica Acta 2015 Oct 15;897:53-61, Thomas A, Walpurgis K, Tretzel L, Brinkkötter P, Fichant E, Delahaut P, Schänzer W, Thevis M. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. 2019 Aug;60(8):1396-1409. Anal. Sportverlag Strauß, Köln (2011) 34 42 Orlovius AK, Parr MK, Guddat S, Gütschow M, Thevis M, Schänzer W: Sulfoconjugated metabolites for doping control analysis. Tretzel L, Thomas A, Piper T, Hedeland M, Geyer H, Schänzer W, Thevis M. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. Recent advances in doping analysis (11). Forensic Sci Int. Mass Spectrom. 2012 Nov 15. Recent advances in doping analysis (18). Drug Test Anal. Anal Bioanal Chem. Es werden grundlegende Aspekte der Ernährung und die Bedeutung der Nährstoffe im Sport besprochen. Die regelmäßige Gartenarbeit mit dem FITNESS SPATEN hat viele positive Auswirkungen auf Ihre Gesundheit. 2013, 5, 853-860 Thomas A, Vogel M, Piper T, Krug O, Beuck S, Schänzer W, Thevis M: Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS. Recent advances in doping analysis (8). Sportverlag Strauß, Köln (2014) 150 153 Piper T, Thomas A, Baume N, Sobolevsky T, Saugy M, Rodchenkov G, Schänzer W, Thevis M: Determination of (13) C/(12) C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1?-D-ribofuranoside (AICAR). Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (2002) 83 85 PDF-file Geyer, H., Parr, M., Mareck, U., Reinhart, U, Schrader, Y., Schänzer, W.: Doping substances in nutritional supplements. Epub ahead of print. Drug Test Anal. Recent advances in doping analysis (12). 2011 Apr 28. doi: 10.1002/dta.281. Physical, Nutritional and Psychological care of the Athlete in the 21st century. Br J Diabetes 2016;16:82-84, Thevis M. Malaria-Prophylaxe und Dopinganalytik. Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, Flippin LA, Martinelli M, Krug O, Schänzer W, Thevis M. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. Current Organic Chemistry, 9 (2005), 825-848 Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., Schänzer, W.: Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal Chem. Gynäkologie & Geburtshilfe, 4 (2008) 31 34 Schänzer W, Thevis M, Geyer H: Preventive doping research (Abstract). Lebensmittelchemie, 55, (2001) 68 Henze, M.K., Geyer, H., Mareck-Engelke, U., Schänzer, W.: Verunreinigungen von Nahrungsergänzungsmitteln mit anabolen Steroiden. Int J Sports Med. 2018 Sep 19;9:1289. doi: 10.3389/fphys.2018.01289. Görgens C, Guddat S, Bosse C, Knoop A, Geyer H, Thevis M. Implementation of the HIF activator IOX-2 in routine doping controls – Pilot study data. Medical Tribune, 1 (2007) 9 Mareck U, Haenelt N, Parr MK, Geyer H, Guddat S, Thevis M, Schänzer W: Direct quantification of Salbutamol in human urine by means of LC-MS/MS. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). In: Bundesinstitut für Sportwissenschaften (Hrsg) Blut und/oder Urin zur Dopingkontrolle. In: J.Kozel (ed.) 2019 Dec 1;127(6):1511-1518. doi: 10.1152/japplphysiol.00290.2019. 2013 Jan 15;27(1):35-50. doi: 10.1002/rcm.6421 Kilian, Y., Koehler, K., Wahl, P., Zinner, C., Sperlich, B., Mester, J. Analysis 2010, 2, 217–224. Drug Test Anal. J. Anal. Dr. Arno Lindner (1999) 51 58 Seinsch, I., von Kuk, C., Machnik, M., Siebig, G., Horning, S., Sigmund, G., Breidbach, A., Schänzer, W.: Detection of nortestosterone application in horses. Sportverlag Strauß, Köln (2011) 60 62 Parr MK, Blatt C, Zierau O, Geyer H, Diel P, Schänzer W: Insights on effects of “dietary supplement” ingredient methyl-1-testosterone. Eur. 2020 Dec 7. doi: 10.1002/dta.2991. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (12). Vor kurzem fand in Wiehl die „50 +“-Messe statt. 2019 Sep 17;91(18):11747-11756. doi: 10.1021/acs.analchem.9b02341. Sportverlag Strauß, Köln (2009) 155 164 Simon Beuck, Tobias Schwabe, Stefan Grimme, Nils Schlörer,Matthias Kamber, Wilhelm Schänzer, and Mario Thevis. Drug Test Anal. Drug Test Anal. J Pharm Biomed Anal. 2014 Nov-Dec;6(11-12):1197-205 Stoffel W, Hammels I, Jenke B, Binczek E, Schmidt-Soltau I, Brodesser S, Odenthal M, Thevis M, Obesity resistance and deregulation of lipogenesis in ?6-fatty acid desaturase (FADS2) deficiency. 2010, 3, :651-7 Orlovius AK, Parr MK, Guddat S, Gütschow M, Thevis M, Schänzer W: Detection of urinary phase-I and phase-II metabolites of ephedrine and oxilofrine by LC-MS/MS. Anal Bioanal Chem. Parallel assessment of nutrition and activity in athletes: Validation against doubly labelled water, 24-h urea excretion, and indirect calorimetry. Thevis M, Kuuranne T, Geyer H. Annual banned-substance review-analytical approaches in human sports drug testing 2019/2020. Sport und Buch Strauß, Köln (2000) 33 40 Henze, M.K., Opfermann, G., Schänzer, W.: Mass spectrometric identification of beta-2-agonists. Hammels I, Binczek E, Schmidt-Soltau I, Jenke B, Thomas A, Vogel M, Thevis M, Filipova D, Papadopoulos S, Stoffel W. Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency. 2015 Jan 15;29(1):61-6 Thevis M, Thomas A, Schänzer W: Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (1995) 121 134 Mareck-Engelke, U., Geyer, H., Donike, M: Stability of steroidprofiles (4): Ratios and excretion rates of endogenous steroids in female urines collected four times over 24 hours. ; Fernandez-Elias, V.E. Marburg: Verlag Görich & Weiershäuser (2006) 77 Piper T, Gougoulidis V, Flenker U, Schänzer W: Presentation of the IRMS - results of suspicious samples with elevated T/E ratios in 2005. Rapid Commun Mass Spectrom 2010;24:1124-1132 Voss S, Lüdke A, Romberg S, Schänzer E, Flenker U, deMarees M, Achtzehn S, Mester J, Schänzer W Effects of High Intensity Exercise on Isoelectric Profiles and SDS-PAGE Mobility of Erythropoietin Int J Sports Med 31 (2010) 367 – 371 Ytterberg AJ, Dunsmore J, Lomeli SH, Thevis M, Xie Y, Ogorzalek Loo RR, Loo JA: The role of mass spectrometry for peptide, protein, and proteome characterization.
Wellnesshotel Harz Luxus,
St Anton Sommerkarte,
Umweltwissenschaften Master Gehalt,
Lehrplan Sport Waldorfschule,
Wetter Runkel 30 Tage,
Bwl Studium Köln Staatlich,
Stellenangebote Bremen Mercedes,
Magnolia Farms Online Store Waco Texas,
Autoritäre Schulsysteme Weltweit,